Skip to content

Caltrate adds 3-in-1 Bone & Joint Health supplement to lineup

Pfizer Consumer Healthcare has rolled out Caltrate Bone & Joint Health, described as a triple-action supplement to promote bone health.

Table of Contents

MADISON, N.J. — Pfizer Consumer Healthcare has rolled out Caltrate Bone & Joint Health, described as a triple-action supplement to promote bone health.

Pfizer said Tuesday that the once-daily Caltrate Bone & Joint Health, now available exclusively at Walgreens, provides three benefits in one supplement: UC-II, an exclusive form of collagen, to support healthy cartilage and promote joint flexibility; calcium and vitamin D3 to nourish strong and healthy bones; and vitamin C and minerals to support collagen production for healthy bones and skin.

“We have developed this unique three-in-1 formulation in one convenient tablet because we know consumers want easier ways to get both bone strength and joint flexibility,” stated Bryna LaMonica, brand manager for Caltrate.

The National Osteoporosis Foundation estimates that 54 million U.S. adults age 50 and older are affected by osteoporosis and low bone mass, and many seek to support their bone health and joint flexibility to maintain an active lifestyle, according to Elizabeth Ward, a registered dietitian and nutrition health expert.

“A once-daily supplement that contains calcium, vitamins C and D, minerals like zinc, copper and manganese, and UC-II allows consumers to get the nutrients that are critical to help maintain strong bones and support flexible joints,” explained Ward.

Comments

Latest